EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy and Safety of Dual Paclitaxel and Sirolimus Nanoparticle-Coated Balloon

Kenji Kawai, Mohammed Tanjimur Rahman, Ryan Nowicki, Frank D Kolodgie, Atsushi Sakamoto, Rika Kawakami, Takao Konishi, Renu Virmani, Vinod Labhasetwar, Aloke V Finn

JACC: Basic to Translational Science · 2024-06 · 9 (6) · 774-789

DOI: 10.1016/j.jacbts.2024.02.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC: Basic to Translational Science, 2024-06. Verfasst von Kenji Kawai und 9 weiteren Autor:innen. Beteiligte Einrichtung: CVPath Institute, Gaithersburg, Maryland, USA. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We evaluated a novel dual active pharmaceutical ingredient (API) drug-coated balloon (DCB), which consists of a coating of nanoparticles encapsulating low-dose paclitaxel (PTX) in combination with sirolimus in a synergistic ratio. Compared to the PTX DCB, the dual API DCB demonstrated similar inhibition of cell proliferation in vitro but at a significantly lower total drug dose (over 13 times lower than sirolimus nanoparticles). Animal experiments demonstrated that the dual API DCB is more effective in inhibiting intimal cell proliferation with insignificant downstream embolic effects and myocardial damage compared to the PTX DCB. These findings indicate that dual API DCBs have a high potential to demonstrate improved clinical outcomes and a greater safety profile than the PTX DCBs.

Schlagwörter

Stichwörter der Autor:innen

downstream embolizationdrug-coated balloonmyocardium injurypreclinical researchvascular response

Autor:innen und Institutionen

  • CVPath Institute, Gaithersburg, Maryland, USA.
  • Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Advanced NanoTherapies, Inc, Los Gatos, California, USA.
  • University of Maryland, School of Medicine, Baltimore, Maryland, USA.

Zitieren

APA

Kawai, K., Rahman, M. T., Nowicki, R., Kolodgie, F. D., Sakamoto, A., Kawakami, R., Konishi, T., Virmani, R., Labhasetwar, V., & Finn, A. V. (2024). Efficacy and Safety of Dual Paclitaxel and Sirolimus Nanoparticle-Coated Balloon. JACC: Basic to Translational Science, 9(6), 774-789. https://doi.org/10.1016/j.jacbts.2024.02.002

Vancouver

Kawai K, Rahman MT, Nowicki R, Kolodgie FD, Sakamoto A, Kawakami R, et al. Efficacy and Safety of Dual Paclitaxel and Sirolimus Nanoparticle-Coated Balloon. JACC: Basic to Translational Science. 2024;9(6):774-789. doi:10.1016/j.jacbts.2024.02.002

BibTeX
@article{Kawai2024,
  author = {Kawai, Kenji and Rahman, Mohammed Tanjimur and Nowicki, Ryan and Kolodgie, Frank D and Sakamoto, Atsushi and Kawakami, Rika and Konishi, Takao and Virmani, Renu and Labhasetwar, Vinod and Finn, Aloke V},
  title = {Efficacy and Safety of Dual Paclitaxel and Sirolimus Nanoparticle-Coated Balloon},
  journal = {JACC: Basic to Translational Science},
  year = {2024},
  volume = {9},
  number = {6},
  pages = {774--789},
  doi = {10.1016/j.jacbts.2024.02.002}
}
Kostenlos starten →